Cargando…

Clostridioides difficile: A diagnostic intervention

Background: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infection and is associated with increased morbidity and mortality. Multiple strategies have been implemented to optimize the diagnostic accuracy of CDI testing algorithms. However, overdiagnosis of C. d...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsoubani, Majd, Khuvis, Joshua, Rodday, Angie, Doron, Shira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614884/
http://dx.doi.org/10.1017/ash.2022.106
_version_ 1784820292979261440
author Alsoubani, Majd
Khuvis, Joshua
Rodday, Angie
Doron, Shira
author_facet Alsoubani, Majd
Khuvis, Joshua
Rodday, Angie
Doron, Shira
author_sort Alsoubani, Majd
collection PubMed
description Background: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infection and is associated with increased morbidity and mortality. Multiple strategies have been implemented to optimize the diagnostic accuracy of CDI testing algorithms. However, overdiagnosis of C. difficile colonization remains a challenge especially in the era of highly sensitive Nucleic acid amplification testing (NAAT). We implemented 2 interventions to reduce the rates of inappropriate C. difficile orders and tests. Methods: We performed a quasi-experimental retrospective study to examine the rates of all inpatient C. difficile test orders and results relative to 2 interventions between January 2018 and February 2021. We defined 3 periods: preintervention, after the first intervention, and after the second intervention. The first intervention, implemented May 2019, was a clinical decision support system (CDSS) tool to guide clinicians to order testing only if CDI criteria were met. The second intervention, implemented July 2020, was the requirement of mandatory antimicrobial team approval of PCR reflex testing for indeterminate toxin or antigen test results. This intervention included a discussion between clinicians and members of stewardship team prior to approval. To evaluate the impact of interventions on ordering appropriateness, chart review was conducted on a random subsample of 100 orders from each period. Hospital-onset CDI (HO-CDI) was calculated using CDC criteria. Results: In total, 3,004 C. difficile test orders were placed during the study period. The rates of reportable HO-CDI were significantly reduced by 57.1% (P = .003). We detected a significant reduction in the number of tests ordered over time from 11.6 to 7.51 per 1,000 patient days. (p Conclusions: CDSS tools target patients at high pretest probability of CDI. The restriction of PCR-reflex testing to the antimicrobial stewardship team is a novel effective measure to minimize the misdiagnosis of CDI. The incorporation of multiple strategies is necessary to improve the diagnostic accuracy of C. difficile testing. Funding: None Disclosures: None
format Online
Article
Text
id pubmed-9614884
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-96148842022-10-29 Clostridioides difficile: A diagnostic intervention Alsoubani, Majd Khuvis, Joshua Rodday, Angie Doron, Shira Antimicrob Steward Healthc Epidemiol C. difficile Background: Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infection and is associated with increased morbidity and mortality. Multiple strategies have been implemented to optimize the diagnostic accuracy of CDI testing algorithms. However, overdiagnosis of C. difficile colonization remains a challenge especially in the era of highly sensitive Nucleic acid amplification testing (NAAT). We implemented 2 interventions to reduce the rates of inappropriate C. difficile orders and tests. Methods: We performed a quasi-experimental retrospective study to examine the rates of all inpatient C. difficile test orders and results relative to 2 interventions between January 2018 and February 2021. We defined 3 periods: preintervention, after the first intervention, and after the second intervention. The first intervention, implemented May 2019, was a clinical decision support system (CDSS) tool to guide clinicians to order testing only if CDI criteria were met. The second intervention, implemented July 2020, was the requirement of mandatory antimicrobial team approval of PCR reflex testing for indeterminate toxin or antigen test results. This intervention included a discussion between clinicians and members of stewardship team prior to approval. To evaluate the impact of interventions on ordering appropriateness, chart review was conducted on a random subsample of 100 orders from each period. Hospital-onset CDI (HO-CDI) was calculated using CDC criteria. Results: In total, 3,004 C. difficile test orders were placed during the study period. The rates of reportable HO-CDI were significantly reduced by 57.1% (P = .003). We detected a significant reduction in the number of tests ordered over time from 11.6 to 7.51 per 1,000 patient days. (p Conclusions: CDSS tools target patients at high pretest probability of CDI. The restriction of PCR-reflex testing to the antimicrobial stewardship team is a novel effective measure to minimize the misdiagnosis of CDI. The incorporation of multiple strategies is necessary to improve the diagnostic accuracy of C. difficile testing. Funding: None Disclosures: None Cambridge University Press 2022-05-16 /pmc/articles/PMC9614884/ http://dx.doi.org/10.1017/ash.2022.106 Text en © The Society for Healthcare Epidemiology of America 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle C. difficile
Alsoubani, Majd
Khuvis, Joshua
Rodday, Angie
Doron, Shira
Clostridioides difficile: A diagnostic intervention
title Clostridioides difficile: A diagnostic intervention
title_full Clostridioides difficile: A diagnostic intervention
title_fullStr Clostridioides difficile: A diagnostic intervention
title_full_unstemmed Clostridioides difficile: A diagnostic intervention
title_short Clostridioides difficile: A diagnostic intervention
title_sort clostridioides difficile: a diagnostic intervention
topic C. difficile
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614884/
http://dx.doi.org/10.1017/ash.2022.106
work_keys_str_mv AT alsoubanimajd clostridioidesdifficileadiagnosticintervention
AT khuvisjoshua clostridioidesdifficileadiagnosticintervention
AT roddayangie clostridioidesdifficileadiagnosticintervention
AT doronshira clostridioidesdifficileadiagnosticintervention